{
  "retracted": false,
  "timestamp": 1349913600000,
  "updates": [
    {
      "timestamp": 1574372708670,
      "identifier": {
        "doi": "10.2165/11585540-000000000-00000"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.2165/11533000-000000000-00000"
  },
  "journal": "PharmacoEconomics",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?"
}
